Exponent/$EXPO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Exponent
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Ticker
$EXPO
Sector
Primary listing
Industry
Professional Services
Headquarters
Employees
966
ISIN
US30214U1025
Website
Exponent Metrics
BasicAdvanced
$3.9B
37.24
$2.04
0.96
$1.16
1.58%
Price and volume
Market cap
$3.9B
Beta
0.96
52-week high
$114.30
52-week low
$72.43
Average daily volume
338K
Dividend rate
$1.16
Financial strength
Current ratio
3.322
Quick ratio
3.162
Long term debt to equity
16.875
Total debt to equity
18.151
Dividend payout ratio (TTM)
55.92%
Profitability
EBITDA (TTM)
143.133
Gross margin (TTM)
39.16%
Net profit margin (TTM)
20.34%
Operating margin (TTM)
25.69%
Effective tax rate (TTM)
27.09%
Revenue per employee (TTM)
$540,000
Management effectiveness
Return on assets (TTM)
11.96%
Return on equity (TTM)
25.87%
Valuation
Price to earnings (TTM)
37.241
Price to revenue (TTM)
7.499
Price to book
8.75
Price to tangible book (TTM)
9
Price to free cash flow (TTM)
28.994
Free cash flow yield (TTM)
3.45%
Free cash flow per share (TTM)
262.06%
Dividend yield (TTM)
1.53%
Forward dividend yield
1.58%
Growth
Revenue change (TTM)
2.58%
Earnings per share change (TTM)
3.59%
3-year revenue growth (CAGR)
5.39%
10-year revenue growth (CAGR)
5.90%
3-year earnings per share growth (CAGR)
2.77%
10-year earnings per share growth (CAGR)
10.38%
3-year dividend per share growth (CAGR)
10.72%
10-year dividend per share growth (CAGR)
15.82%
What the Analysts think about Exponent
Analyst ratings (Buy, Hold, Sell) for Exponent stock.
Bulls say / Bears say
Exponent's total revenues increased by 4.6% to $536.8 million in fiscal year 2023, indicating steady growth. (investors.exponent.com)
The company announced an increase in its quarterly cash dividend from $0.26 to $0.28, reflecting confidence in its financial health. (investors.exponent.com)
Exponent's engineering and other scientific segment, representing 83% of revenues, saw an 8% increase in revenues before reimbursements during fiscal year 2023, driven by demand in transportation and energy sectors. (investors.exponent.com)
Net income decreased to $20.9 million in Q4 2023, down from $22.5 million in the same period of 2022, indicating a decline in profitability. (investors.exponent.com)
The environmental and health segment experienced a 3% decrease in revenues before reimbursements in Q4 2023, impacted by client budget constraints and delays in litigation work. (investors.exponent.com)
The company anticipates revenues before reimbursements to be flat to down modestly in 2024, reflecting potential challenges in maintaining growth. (investors.exponent.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.
Exponent Financial Performance
Revenues and expenses
Exponent Earnings Performance
Company profitability
Exponent News
AllArticlesVideos
Exponent to Announce Second Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on July 31, 2025
GlobeNewsWire·19 hours ago
Exponent Reports First Quarter 2025 Financial Results
GlobeNewsWire·2 months ago
Exponent Declares Regular Quarterly Dividend for Q2 2025
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Exponent stock?
Exponent (EXPO) has a market cap of $3.9B as of July 11, 2025.
What is the P/E ratio for Exponent stock?
The price to earnings (P/E) ratio for Exponent (EXPO) stock is 37.24 as of July 11, 2025.
Does Exponent stock pay dividends?
Yes, the Exponent (EXPO) stock pays dividends to shareholders. As of July 11, 2025, the dividend rate is $1.16 and the yield is 1.58%. Exponent has a payout ratio of 55.92% on a trailing twelve-month basis.
When is the next Exponent dividend payment date?
The next Exponent (EXPO) dividend payment date is unconfirmed.
What is the beta indicator for Exponent?
Exponent (EXPO) has a beta rating of 0.96. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.